Monday, August 16, 2021 11:31:17 PM
The Company is a 49% owner of the Bulgarian entity IMMB BG, which holds a sub-license agreement issued by ENZC for the proprietary immunotherapy treatment.
The Company is 100% owner of Biogenysis, Inc.
The Company is 100% owner of Virogentics, Inc.
The Company is 100% owner of ENZC Sub., Inc.
The Company is 100% owner of BioClonetics Immunotherapy, Inc.
Well, sub license agreement. Still tied to them.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM